Examination of the efficacy and safety of Doripenem for hospital-aquired pneumonia
- Conditions
- Hospital-acquired pneumonia patient
- Registration Number
- JPRN-UMIN000004408
- Lead Sponsor
- Hamamatsu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Not provided
The patient who corresponds to either the following excludes it from the object of the examination 1:Patient who is administering valproate sodium 2:Patient who has the past of shock or hypersensitivity for this medicine 3:Patient with liver dysfunction AST(GOT):100IU/L or more, ALT(GTP):100IU/L or more 4:Patient who has disease of central nervous system or with the past of epilepsy 5:Patient who has allergy or serious side effect in betalactam system medicine 6:Patient who has been put in to examination once 7:Patient who participated in other clinical trials and clinical researches within four months in the past 8:Patient who needs using prohibition medicine 9:patient whom conducting of the examination doctor judged that pursuit of right evaluation and enough passage is impossible 10:Pediatrics 11:Patient who corresponds to PS4
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical effectiveness
- Secondary Outcome Measures
Name Time Method safety profile, PK